Simplex Secures Investment from Camelot Venture Group
"Simplex is very fortunate to have Camelot as part of our investment group and David as part of the board," said CEO Doug Hudson, Chairman and CEO of Simplex. "I've known David for many years and his direct to consumer experience and marketing expertise will be invaluable to Simplex."
Simplex, a leading provider of diabetic testing supplies, has grown dramatically since it was founded in 2007. The Center for Disease Control estimates that nearly 21 million Americans are diabetic and an additional 41 million are pre-diabetic (elevated blood sugar levels). Almost 1.3 million new diabetics are diagnosed each year with the expectation that this will continue to grow due to an aging population and increased obesity in the US.
"I'm excited to be a part of Simplex" said David Katzman. "Doug, his management team and the board have done an impressive job of building the company to this point. I look forward to helping them expand their vision and growth."
About Camelot Venture Group
About Simplex Healthcare, Inc